Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Howell

Showing results (281-290 of 339) with videos related to

Pageof 34
Sort By:
Journal of Medical Genetics|November 28, 2022
Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancersD Gareth Evans, Siva Sithambaram, Elke Maria van Veen, et al.
Cell Cycle (Georgetown, Tex.)|September 4, 2010
Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cellsUbaldo E Martinez-Outschoorn, Renee M Balliet, Dayana B Rivadeneira, et al.
Cell Cycle (Georgetown, Tex.)|September 22, 2010
Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironmentUbaldo E Martinez-Outschoorn, Casey Trimmer, Zhao Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 31, 2023
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descentEleanor Roberts, Elke M van Veen, Helen Byers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 16, 2023
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descentEleanor Roberts, Elke M van Veen, Helen Byers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 11, 2021
Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancerEmma R Woodward, Elke M van Veen, Claire Forde, et al.
British Journal of Cancer|March 30, 2016
Breast cancer risk feedback to women in the UK NHS breast screening populationD Gareth R Evans, Louise S Donnelly, Elaine F Harkness, et al.
Breast Cancer Research and Treatment|September 3, 2010
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapyAlastair M Thompson, Andrea Johnson, Philip Quinlan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Pageof 34

Showing results (281-290 of 339) with videos related to

Sort By:
Pageof 34
Journal of Medical Genetics|November 28, 2022
Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancersD Gareth Evans, Siva Sithambaram, Elke Maria van Veen, et al.
Cell Cycle (Georgetown, Tex.)|September 4, 2010
Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cellsUbaldo E Martinez-Outschoorn, Renee M Balliet, Dayana B Rivadeneira, et al.
Cell Cycle (Georgetown, Tex.)|September 22, 2010
Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironmentUbaldo E Martinez-Outschoorn, Casey Trimmer, Zhao Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 31, 2023
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descentEleanor Roberts, Elke M van Veen, Helen Byers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 16, 2023
Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descentEleanor Roberts, Elke M van Veen, Helen Byers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 11, 2021
Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancerEmma R Woodward, Elke M van Veen, Claire Forde, et al.
British Journal of Cancer|March 30, 2016
Breast cancer risk feedback to women in the UK NHS breast screening populationD Gareth R Evans, Louise S Donnelly, Elaine F Harkness, et al.
Breast Cancer Research and Treatment|September 3, 2010
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapyAlastair M Thompson, Andrea Johnson, Philip Quinlan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Pageof 34